https://medicine.ouhsc.edu/Academic-Departments Parent Page: Academic Departments id: 23201 Active Page: Faculty and Staffid:23396

Faculty and Staff

Jonea Lim, MD
Internal Medicine

Jonea Lim, MD

Associate Professor
Associate Fellowship Director


1000 N. Lincoln Blvd., HHDC 2900
Oklahoma City, OK 73104-3252

(405) 271-5896

Jonea-Lim@ouhsc.edu


Academic Section(s):

Endocrinology and Diabetes


Education:

  • 1998 - 2002       Doctor of Medicine, Faculty of Medicine & Surgery, University of Santo Tomas, Philippines


Residency:

  • 2005 - 2008       Internal Medicine, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK


Fellowship:

  • 2008 - 2011      Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Oklahoma Health Science Center, Oklahoma City, OK


Select Publications:

Lim, J. (in press). Spontaneous Cerebrospinal Fluid Leak after Initiation of Dopamine Agonist Therapy in Macroprolactinomas. AACE.

Talsania, M. S., Sharma, R., Sughrue, M. E., Scofield, R. H., Lim, J. (2017). Familial Pallister-Hall in adulthood. Neuro endocrinology letters, 38(5), 329-331. PMID: 29106787.

Mann JFE, Ørsted, D. D., Brown-Frandsen, K., Marso, S. P., Poulter, N. R., Rasmussen, S., Tornøe, K., Zinman, B., Buse, J. B., LEADER Steering Committee and Investigators (2017). Liraglutide and Renal Outcomes in Type 2 Diabetes. The New England journal of medicine, 377(9), 839-848. PMID: 28854085. DOI: 10.1056/NEJMoa1616011.

Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R., Pratley, R. E., Haahr, P. M., Lange, M., Brown-Frandsen, K., Moses, A., Skibsted, S., Kvist, K., Buse, J. B., DEVOTE Study Group (2017). Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. The New England journal of medicine, 377(8), 723-732. PMID: 28605603. DOI: 10.1056/NEJMoa1615692.

Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., Woo, V., Hansen, O., Holst, A. G., Pettersson, J., Vilsbøll, T., SUSTAIN-6 Investigators (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. The New England journal of medicine, 375(19), 1834-1844. PMID: 27633186. DOI: 10.1056/NEJMoa1607141.

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., Steinberg, W. M., Stockner, M., Zinman, B., Bergenstal, R. M., Buse, J. B., LEADER Steering Committee on behalf of the LEADER Trial Investigators (2016). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. The New England journal of medicine, 375(4), 311-22. PMID: 27295427. DOI: 10.1056/NEJMoa1603827.